Physician profile
Anna M Russell
NPI 1003578642
$856.24
in general payments reported to CMS, 2019-2025
13 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.36 · 2023: $40.16 · 2024: $401 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $119.05 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.60 | 2024 | Jardiance |
| Olympus America INC. | $113.49 | 2024 | Single Use Biliary Balloon Dilator, Single Use Aspiration Needle Na-U200h |
| Gilead Sciences, INC. | $109.31 | 2025 | Epclusa |
| Novartis Pharmaceuticals Corporation | $93.93 | 2024 | |
| Alnylam Pharmaceuticals INC. | $76.45 | 2024 | Onpattro |
| Corcept Therapeutics | $67.31 | 2025 | Korlym |
| Medtronic, INC. | $65.58 | 2025 | Venaseal |
| Abbott Laboratories | $21.59 | 2023 | Freestyle Libre 2 |
| Abbvie INC. | $19.94 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.60 | 2022 | |
| Kyowa Kirin, INC. | $18.57 | 2023 | Crysvita |
| Pfizer INC. | $14.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.